The Feng Symposium on Prostate Cancer Revolutions
Hosted by the UCSF Benioff Initiative for Prostate Cancer Research
The Feng Symposium aims to bring together the most diverse group of cancer researchers— bench science, translational, and clinical disciplines—to provide a single forum for a discussion of novel state-of-the-art therapeutic approaches to prostate cancer. Presentations will be provided by the world’s top prostate cancer investigators from academia and industry, including the leaders of the American Cancer Society and The Prostate Cancer Foundation, and the Presidents of ASCO and ASTRO. The meeting will be anchored around three topic areas, each lead by a panel of discussion leaders:
1. Discovery Science
2. Translational Research
3. Clinical Application
The unique approach of this symposium allows all the conference attendees to bond and form scientific connections across the whole spectrum of prostate cancer research.
2025 Organizing Committee
Himisha Beltran, MD
Dana-Farber Cancer Institute.
Himanshu Nagar, MD, MS
Memorial Sloan Kettering Cancer Center
Founding Organizers
-
Dr. Felix Feng
Chair
Dr. Feng is a professor of Radiation Oncology, Urology, and Medicine at the University of California, San Francisco. He serves as the Vice Chair for Translational Research in the Department of Radiation Oncology, and Associate Director for Translational Clinical Research in the Helen Diller Family Comprehensive Cancer Center. He is the director of the UCSF Benioff Initiative for Prostate Cancer Research.
-
Dr. Paul Nguyen
Co-Chair
Dr. Nguyen serves as the DF/BWCC Genitourinary Clinical Center Director for Radiation Oncology, Vice-Chair for Clinical Research in the Department of Radiation Oncology, Professor at Harvard Medical School, and Baldwin-Politi Distinguished Chair in Oncology at Brigham and Women's Hospital where he is also associate director of the Harvard Radiation Oncology Program residency.
-
Dr. Josh Lang
Co-Chair
Dr. Lang serves as the Associate Director of Translational Research at the University of Wisconsin Carbone Cancer Center, Vice Chair of Biomedical Research in the University of Wisconsin Department of Medicine, and Professor of Medicine in the Division of Hematology, Oncology and Palliative Care. He is a Vilas Distinguished Achievement Professor at the University of Wisconsin. He also serves as co-Director of the Physician Scientist Training Program in the Department of Medicine.